「fo」の検索結果
123件：26～30件目を表示
-
临床试验信息 | 研究与开发 | 千寿制药株式会社
444 Healthy Volunteers 1 SJP-0008 Japan Completed jRCT2031210280 Disclaimer This website provides information on clinical trials sponsored by SENJU PHARMACEUTICAL Co., Ltd. (hereinafter referred to as...
http://www.senju.co.jp/chinese/rd/trial.html -
产品开发方针 | 研究与开发 | 千寿制药株式会社
heng CY, et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health. 2014;2(2):e106-16. #1...
http://www.senju.co.jp/chinese/rd/policy/ -
发表论文 | 研究与开发 | 千寿制药株式会社
almology. 2026;283:163-175. VIEW PUBLICATION Cost‑effectiveness Analysis of Ranibizumab Biosimilar for Neovascular Age‑Related Macular Degeneration and its Subtypes from the Societal and Patient Pers...
http://www.senju.co.jp/chinese/rd/thesis/ -
研究開発の取り組み | 千寿製薬株式会社
ties Product Development Policy Research and Development System R & D Pipeline Clinical trial information Publications Meetings of the Minds Business Collaboration Inquiries licensing★senju.co.jp*...
http://www.senju.co.jp/english/rd/ -
Company Profile | About Senju | SENJU Pharmaceutical
Corporate Name Senju Pharmaceutical Co.,Ltd. Headquarter 3-1-9, Kawara-machi, Chuo-ku, Osaka 541-0048,Japan TEL：+81-6-6201-2512 FAX：+81-6-6226-0406 Date of Incorporation April 9, 1947 Capital 1,415,50
http://www.senju.co.jp/english/about/outline.html